Abstract
Olanzapine increases brain allopregnanolone (ALLO) levels sufficiently to modulate neuronal activity by allosterically regulating GABAA receptors. Recently, we reported the antipsychotic-like profile of ALLO in rodents. The present study examined the hypothesis that olanzapine-induced elevation of endogenous neurosteroid ALLO is vital for its neuroleptic-like action. The conditioned avoidance response (CAR) and apomorphine-induced climbing behavioral paradigms were used in rodents. Administration of ALLO (1 μg, intracerebroventricular (i.c.v.)) or neurosteroidogenic agents such as the mitochondrial diazepam binding inhibitor receptor agonist, FGIN 1-27 (0.5 μg, i.c.v.) or the ALLO precursor, progesterone (10 mg/kg, i.p.) significantly potentiated olanzapine-induced blockade of CAR and apomorphine-induced climbing. In contrast, these agents failed to alter the antipsychotic-like effect of risperidone and haloperidol. On the other hand, inhibition of the endogenous biosynthesis of neurosteroids by the 3β-hydroxysteroid dehydrogenase inhibitor, trilostane (30 mg/kg, i.p.), the 3α-hydroxysteroid oxidoreductase inhibitor, indomethacin (5 mg/kg, i.p.), or the GABAA receptor antagonist bicuculline (1 mg/kg, i.p.) and dehydroepiandrosterone sulfate (DHEAS) (1 mg/kg, i.p.) blocked the effect of olanzapine, but not of risperidone and haloperidol. Socially isolated animals, known to exhibit decreased brain ALLO and GABAA receptor functions, displayed a shortening in the muscimol-induced loss of righting reflex and an increased susceptibility to apomorphine-induced climbing. Administration of olanzapine, but not of haloperidol and risperidone, normalized the duration of muscimol-elicited loss of righting reflex. Although all three antipsychotics proved capable of antagonizing the apomorphine-induced climbing, a dose almost five times higher of olanzapine was required in socially isolated animals. The data obtained suggest that enhancement of the GABAergic tone plays a key role in the antipsychotic-like effect exerted by olanzapine in rodents, likely as a consequence of augmented levels of neuroactive steroids, in particular ALLO, in the brain. The present findings provide the first specific behavioral evidence in support of the hypothesis that neuroactive steroid ALLO- mediated GABAergic modulation is essential for the antipsychotic-like action of olanzapine.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE (1995). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52: 258–266.
Akwa Y, Ladurelle N, Covey DF, Baulieu E (2001). The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms? Proc Natl Acad Sci USA 98: 14033–14037.
Arnt J (1982). Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51: 321–329.
Bailey JW, Cohen LS (1999). Prevalence of mood and anxiety disorders in women who seek treatment for premenstrual syndrome. J Womens Health Gend Based Med 8: 1181–1184.
Barbaccia ML, Affricano D, Purdy RH, Maciocco E, Spiga F, Biggio G (2001). Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. Neuropsychopharmacology 25: 489–497.
Bartholini G (1980). Interaction of striatal dopaminergic, cholinergic and GABAergic neurons: relation to extrapyramidal function. Trends Pharmacol Sci 1: 138–140.
Baulieu EE, Robel P, Schumacher M (2001). Neurosteroids: beginning of the story. Int Rev Neurobiol 46: 1–32.
Beasley Jr CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S (1996). Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14: 111–123.
Benes FM (1995). Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Arch Gen Psychiatry 52: 1015–1024.
Benes FM, Berretta S (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25: 1–27.
Beyer C, Gonzalez-Flores O, Ramirez-Orduna JM, Gonzalez-Mariscal G (1999). Indomethacin inhibits lordosis induced by ring a-reduced progestins: possible role of 3α-oxoreduction in progestin-facilitated lordosis. Horm Behav 35: 1–8.
Bilsky EJ, Inturrisi CE, Sadee W, Hruby VJ, Porreca F (1996). Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain 68: 229–237.
Bitran D, Foley M, Audette D, Leslie N, Frye CA (2000). Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology 151: 64–71.
Bixo M, Andersson A, Winblad B, Purdy RH, Backstrom T (1997). Progesterone, 5alpha-pregnane-3, 20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res 764: 173–178.
Brockington IF, Meakin CJ (1994). Clinical clues to the etiology of puerperal psychosis. Prog Neuropsychopharmacol Biol Psychiatry 18: 417–429.
Brunig I, Sommer M, Hatt H, Bormann J (1999). Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci USA 96: 2456–2460.
Brussard AB, Wossink J, Lodder JC, Kits KS (2000). Progesterone metabolite prevents protein kinase C dependent modulation of gamma-aminobutyric acid type A receptors in oxytocin neurons. Proc Natl Acad Sci USA 97: 3625–3630.
Bymaster F, Falcone JF, Bauzon D, Kennedy JS, Schenck K, DeLapp NW et al (2001). Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine. Eur J Pharmacol 430: 341–349.
Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC (1996). Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacol 14: 87–96.
Bymaster FP, Falcon JF (2000). Decreased binding affinity of olanzapine and clozapine for human muscarinic receptor subtypes in intact clonal CHO cells in physiological medium. Eur J Pharmacol 390: 245–248.
Bymaster FP, Moore NA, Nakazawa T (1999). Review of the preclinical pharmacology of olanzapine; a marker of new class of antipsychotic. Jpn J Clin Psychopharmacol 2: 885–911.
Cameron DL, Williams JT (1993). Dopamine D1 receptors facilitate transmitter release. Nature 366: 344–347.
Carpenter WT, Buchanan RW, Kirkpatrick B, Breier AF (1999). Diazepam treatment of early signs of exacerbation in schizophrenia. Am J Psychiatry 156: 299–303.
Costall B, Naylor RJ, Nohria V (1978). Climbing behavior induced by apomorphine in mice: a potential model for the detection of neuroleptic activity. Eur J Pharmacol 1: 39–50.
Dazzi L, Serra M, Vacca G, Ladu S, Latrofa A, Trapani G et al (2002). Depletion of cortical allopregnanolone potentiates stress-induced increase in cortical dopamine output. Brain Res 5: 135–139.
Dong E, Matsumoto V, Uzunova I, Sugaya H, Takahata H, Nomura H et al (2001). Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proct Natl Acad Sci USA 98: 21849–21854.
Drew KL, O’Connor WT, Kehr J, Ungerstedt U (1990). Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. Eur J Pharmacol 23: 385–397.
Farnbach-Pralong D, Bradbury R, Copolov D, Dean B (1998). Clozapine and olanzapine treatment decreases rat cortical and limbic GABAA receptors. Eur J Pharmacol 349: R7–R8.
Finn DA, Gee KW (1993). The influence of estrus cycle on neurosteroid potency at the gamma-aminobutyric acid A receptor complex. J Pharm Exp Ther 265: 1374–1379.
Frye CA (1995). The neurosteroid 3α,5α -THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 696: 113–120.
Frye CA, Seliga A (2003). Effects of olanzapine infusions to the ventral tegmental area on lordosis and midbrain 3α,5α-THP concentrations in rats. Psychopharmacol 170: 132–139.
Genazzani AR, Petraglia F, Bernardi F, Casarosa E, Salvestroni C, Tonetti A et al (1998). Circulating levels of allopregnanolone in humans: gender, age and endocrine influences. J Clin Endocrinol Metab 83: 2099–2103.
George MS, Guidotti A, Rubinow D, Pan B, Mikalauskas K, Post RM (1994). CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI. Biol Psychiatry 35: 775–780.
Gimbalvo CT (1988). Protein kinase C and dopamine release-II. Effect of dopamine acting drugs in vivo. Biochem Pharmacol 37: 4009–4017.
Gruen RJ, Friedhoff AJ, Coale A, Moghaddam B (1992). Tonic inhibition of striatal dopamine transmission: effects of benzodiazepine and GABAA receptor antagonists on extracelllular dopamine levels. Brain Res 599: 51–56.
Guidotti A, Costa E (1998). Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3α, 5α-tetrahydroprogesterone (allopregnanolone) availability? Biol Psychiatry 44: 865–873.
Guidotti A, Dong E, Matsumoto K, Pinna G, Rasmusson AM, Costa E (2001). The socially isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Rev 37: 110–115.
Guidotti A, Pesold C, Costa E (2000). New neurochemical markers for psychosis: a working hypothesis of their operation. Neurochem Res 25: 1207–1218.
Hafner H, Riecher-Rossler A, an der Heiden W, Maurer K, Fatkenheuer B, Lottler W (1993). Generating and testing a casual explanation of gender difference in age at first onset of schizophrenia. Psychol Med 23: 925–940.
Harris B, Lovelt L, Newcombe RG, Read GF, Walker R, Riad-Fahmy D (1994). Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. BMJ 308: 949–953.
Hill M, Parizek A, Bicikova M, Havlikova H, Klak J, Fait T et al (2000). Neuroactive steroids, their precursors, and polar conjugates during parturition and postpartum in maternal and umbilical blood: 1. Identification and simultaneous determination of pregnanolone isomers. J Steroid Biochem Mol Biol 75: 237–244.
Hirani K, Khisti RT, Chopde CT (2002). Behavioral actions of ethanol in Porsolt's forced swim test: modulation by 3alpha-hydroxy-5alpha-pregnan-20-one. Neuropharmacology 43: 1339–1350.
Hodge CW, Raber J, McMahon T, Walter H, Sanchez-Perez AM, Olive MF et al (2002). Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase C epsilon. J Clin Invest 110: 1003–1010.
Kapur S, Zipursky RB, Remington G (1999). Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone and olanzapine in schizophrenia. Am J Psychiatry 156: 286–293.
Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA et al (1998). 5HT2 and D2 receptor occupancy of olanzapine receptor in schizophrenia: a PET investigation. Am J Psychiatry 155: 921–928.
Khisti RT, Chopde CT (2000). Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice. Brain Res 865: 291–300.
Khisti RT, Chopde CT, Abraham E (2000). GABAergic involvement in motor effects of an adenosine A2A receptor agonist in mice. Neurosci Lett 251: 85–88.
Khisti RT, Deshpande LS, Chopde CT (2002). The neurosteroid 3α-hydroxy- 5α-pregnan-20-one affects dopamine-mediated behavior in rodents. Psychopharmacol 161: 120–128.
Khisti RT, Mandhane SN, Chopde CT (1998). The neurosteroid 3α-hydroxy-5α-pregnan-20-one induces catalepsy in mice. Neurosci Lett 251: 85–88.
Korneyev AY, Costa E, Guidotti A (1993). During anesthetic-induced activation of hypothalamic pituitary adrenal axis, blood borne steroid fail to contribute to the anesthetic effect. Neuroendocrinology 57: 559–565.
Kurumaji A, Nomoto H, Yoshikawa T, Okubo Y, Toru M (2000). An association study between two missense variations of the benzodiazepine receptor (peripheral) gene and schizophrenia in a Japanese sample. J Neural Transm 107: 491–500.
Kurumaji A, Wakai T, Toru M (1997). Decreases in peripipheral-type benzodiazepine receptors in postmortem brains of schizophrenics. J Neural Transm Gen Sect 104: 1361–1370.
Lambert JJ, Belelli D, Hill-Venning C, Peters JA (1995). Neurosteroids and GABAA receptor function. Trends Pharmacol Sci 16: 295–303.
Law-Tho D, Hirsch JC, Crepel F (1994). Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci Res 21: 151–160.
Lewis DA (2000). GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Rev 31: 270–276.
Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB (2000). Direct protein–protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature 403: 274–280.
Madhusoodanan S, Brenner R, Cohen CL (1999). Role of atypical antipsychotics in the treatment of psychosis and agitation associated with dementia. CNS Drugs 12: 135–150.
Madhusoodanan S, Sinha S, Brenner R, Gupta S, Bogunovic O (2001). Use of olanzapine for elderly patients with psychotic disorders: a review. Ann Clin Psychiatry 13: 201–213.
Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABAA receptor. Science 232: 1004–1007.
Marx CE, Duncan GE, Gilmore JH, Lieberman JA, Morrow AL (2000). Olanzapine increases allopregnanolone in the rat cerebral cortex. Biol Psychiatry 47: 1000–1004.
Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL (2003). Olanzapine and Clozapine increase the GABAergic Neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28: 1–13.
Matsumoto K, Uzunova V, Pinna G, Taki K, Uzunova DP, Watanabe H et al (1999). Permissive role of brain allopregnanolone content in the regulation of pentobarbital induced righting reflex loss. Neuropharmacology 38: 955–963.
Moore NA, Axton MS (1988). Production of climbing behavior in mice requires both D1 and D2 receptor activation. Psychopharmacology 91: 263–266.
Moore NA, Rees G, Sanger G, Tye NC (1994). Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol 5: 196–202.
Moore NA, Tye NC, Axton MS, Risius FC (1992). The behavioral pharmacology of olanzapine, a novel ‘atypical’ antipsychotic agent. J Pharmacol Exp Ther 262: 545–551.
Morrow AL, Pace JR, Purdy RH, Paul SM (1990). Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol Pharmacol 37: 263–270.
Morrow AL, Suzdak PD, Paul SM (1987). Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. Eur J Pharmacol 142: 483–485.
Motzo C, Porceddu ML, Maira G, Flore G, Concas A, Dazzi L (1996). Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone. J Psychopharmacol 10: 266–272.
Murray HE, Gillies GE (1997). Differential effects of neuroactive steroids on somatostatin and dopamine secretion from primary hypothalamic cell cultures. J Neuroendocrinol 9: 287–295.
Nechmad A, Mayan R, Ramadan E, Morad O, Poyurovsky M, Weizman A (2003). Clozapine decreases rat brain dehydroepiandrosterone and dehydroepiandrosterone sulphate levels. Eur J Neuropsychopharmacol 13: 29–31.
Nowakowska E, Chodera A, Kus K (1999). Influence of olanzapine on cognitive functions and catalepsy in rats after single and chronic administration. Pol J Pharmacol 51: 295–300.
O’Connor WT (2001). Functional neuroanatomy of the ventral striopallidal GABA pathway: new sites of intervention in the treatment of schizophrenia. J Neurosci Methods 109: 31–39.
Oades RD, Schepker R (1994). Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology 19: 373–385.
Orentreich N, Brind H, Rizer RL, Vogehman JH (1984). Age changes and sex difference in dehydroepiandrosterone sulphate concentrations throughout adulthood. J Clin Endocrinol Metab 59: 551–555.
Osborne PG, O’Connor WT, Beck O, Ungerstedt U (1994). Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release. Brain Res 14: 20–30.
Pacitti C, Fiadone G, Gasbari A, Civitelli D, Scarnati E (1982). Electrophysiological evidence for an inhibitory accumbens entopenducular pathway in the rat. Neurosci Lett 33: 35–50.
Paul SM, Purdy RH (1992). Neuroactive steroids. FASEB J 6: 2311–2322.
Paxinos G, Franklin RBJ (1997). The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego.
Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego.
Penit-Soria J, Audinat E, Crepel F (1987). Excitation of rat prefrontal cortical neurons by dopamine: an in vitro electrophysiological study. Brain Res 425: 263–274.
Pennartz CM, Dolleman-Vander Weel MJ, Kitai ST, Lopes Da Silva FH (1992). Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory inputs to the shell region of the rat nucleus accumbens studied in vitro. J Neurophysiol 67: 1325–1334.
Pirot S, Godbout R, Mantz J, Tassin JP, Glowinski J, Thierry AM (1992). Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience 49: 857–865.
Potts GO, Creange JE, Harding HR, Schane HP (1978). Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 32: 257–267.
Pralong E, Jones RS (1993). Interactions of dopamine with glutamate and GABA-mediated synaptic transmission in the rat entorhinal cortex in vitro. Eur J Neurosci 5: 760–767.
Prasad VVK, Vegesna SR, Welch M, Lieberman S (1994). Precursors of neurosterids. Proct Natl Acad Sci USA 91: 3220–3223.
Purdon SE, Labelle A, Boulay L (2001). Neuropsychological change in schizophrenia after 6 weeks of Clozapine. Schizophr Res 48: 57–67.
Purdy RH, Moore Jr PH, Morrow AL, Paul SM (1992). Neurosteroids and GABAA receptor function. Adv Biochem Psychopharmacol 47: 87–92.
Purdy RH, Morrow AL, Moore Jr PH, Paul SM (1991). Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA 15: 4553–4557.
Richelson E, Souder T (2000). Binding of antipsychotic drugs to human brain receptors. Focus on newer generation compounds. Life Sci 68: 29–39.
Robel P, Baulieu EE (1995). Neurosteroids: biosynthesis and function. Crit Rev Neurobiol 9: 383–394.
Robel P, Baulieu EE, Synguelakis M, Halberg E (1987). Chronobiologic dynamics of delta 5-3 beta-hydroxysteroids and glucocorticoids in rat brain and plasma and human plasma. Prog Clin Biol Res 227A: 451–465.
Robel P, Young J, Corpechot C, Mayo W, Perche F, Haug M et al (1995). Biosynthesis and assay of neurosteroids in rats and mice: functional correlates. J Steroid Biochem Mol Biol 53: 355–360.
Robertson GS, Fibiger HC (1996). Effects of olanzapine on regional C-Fos expression in rat forebrain. Neuropsychopharmacology 14: 105–110.
Romeo E, Auta J, Kozikowski AP, Ma D, Papadopoulos V, Puia G (1992). 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J Pharmacol Exp Ther 262: 971–978.
Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ, Shen Y (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268: 1403–1410.
Rupprecht R, Holsboer F (1999). Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22: 410–416.
Rupprecht R, Koch M, Montkowski A, Lancel M, Faulhaber J, Harting J et al (1999). Assessment of neuroleptic-like properties of progesterone. Psychopharmacology 143: 29–38.
Rupprecht R, Reul LMMH, Trapp T, Steensel B, Wetzel C, Damm K et al (1993). Progesterone-receptor mediated effects of neuroactive steroids. Neuron 11: 523–530.
Sanchez-Blazquez P, Garcia-Espana A, Garzon J (1995). In vivo injection of antisense oligodeoxyneucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J Pharmacol Expt Ther 275: 1590–1596.
Santiago M, Westerink BHC (1992). The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats. Eur J Pharmacol 219: 175–181.
Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS et al (1996). Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124: 57–73.
Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJM, Garcia-Segura LM et al (2003). Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71: 3–29.
Serra M, Littera M, Pisu MG, Muggironi M, Purdy RH, Biggio G (2000). Steroidogenesis in rat brain induced by short- and long-term administration of carbamazepine. Neuropharmacology 39: 2448–2456.
Smolders I, de Klippel N, Sarre S, Ebinger G, Michotte Y (1995). Tonic GABAergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat. Eur J Pharmacol 284: 83–91.
Strange PG (2001). Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol Rev 53: 119–133.
Tauscher J, Kufferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C et al (1999). In vivo123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol. Psychopharmacology 141: 175–181.
Twyman RE, Macdonald Rl (1992). Neurosteroid regulation of GABAA receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J Physiol 456: 215–245.
Uzunova V, Melanie C, Kohler C, Uzunov DP, Wrynn AS (2003). Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression. Brain res 796: 1–8.
Van Kammen DP (1977). Gamma-aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 134: 138–143.
Wadenberg MLG, Soliman A, Vanderspek S, Kapur S (2001). Dopamine D2 receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropharmacology 25: 633–641.
Wang M, Seippel L, Purdy RH, Backstorm T (1996). Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulphate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J Clin Endocrinol Metab 81: 1076–1082.
Wieland S, Lan NC, Mirasedeghi S, Gee KW (1991). Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res 565: 263–268.
Zimmerberg B, Blaskey LG (1998). Prenatal stress effects are partially ameliorated by prenatal administration the neurosteroid allopregnanolone. Pharmacol Biochem Behav 59: 819–827.
Acknowledgements
This study was supported by the senior research fellowship grant from Council of Scientific and Industrial Research, New Delhi to KH (CSIR # 9/128(68)/2K2/EMR-I) and emeritus grant of All India Council of Technical Education, New Delhi to CTC (AICTE # 1-51/FD/EF (10)/2002-2003/I). We gratefully acknowledge the support from Regione Autonoma della Sardegna L.R 11/04/1996 n.19 and thank Dr Anne Farmer and Dr NK Subhedar for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ugale, R., Hirani, K., Morelli, M. et al. Role of Neuroactive Steroid Allopregnanolone in Antipsychotic-like Action of Olanzapine in Rodents. Neuropsychopharmacol 29, 1597–1609 (2004). https://doi.org/10.1038/sj.npp.1300460
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300460
Keywords
This article is cited by
-
Antipsychotics increase steroidogenic enzyme gene expression in the rat brainstem
Molecular Biology Reports (2022)
-
Enhanced remyelination during late pregnancy: involvement of the GABAergic system
Scientific Reports (2019)
-
Chronic treatment with serotonin reuptake inhibitor antidepressant (SSRI) combined with an antipsychotic regulates GABA-A receptor in rat prefrontal cortex
Psychopharmacology (2012)
-
The biochemical womb of schizophrenia: A review
Indian Journal of Clinical Biochemistry (2008)
-
The Relevance of Neuroactive Steroids in Schizophrenia, Depression, and Anxiety Disorders
Cellular and Molecular Neurobiology (2007)
